Today, CellaVision announced that the company's Annual Report for 2013 is
available as PDF at www.cellavision.com, and can be read via the link below.
To request a printed version, please visit the investor pages at CellaVision's
For more information, please contact:
Yvonne Mårtensson, CEO.
Phone: +46 708 33 77 82, e-mail: email@example.com
CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other body
fluids in health care services. The products rationalize manual laboratory work,
and secure and support effective workflows and skills development within and
between hospitals. The company has leading-edge expertise in image analysis,
artificial intelligence and automated microscopy. In most countries sales are
via global partners. Products are sold directly in the Nordic countries and via
subsidiaries in the US, Canada and Japan. In 2013 sales were SEK 180 million and
sales continue to increase, with a growth target of at least 15 % per year over
an economic cycle. CellaVision's registered office is in Lund, Sweden. The share
is listed on the Nasdaq OMX Stockholm, Small Cap list. Read more at
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
2321 Rosecrans Avenue.
El Segundo, CA 90245 Phone: (800) 307-6627 Fax: (800) 307-3567
25 Basinghall Street,
London EC2V 5HA
UK Phone: +1 866-465-8454